J. Tucker

发表

Loss of N-Myc interactor promotes epithelial-mesenchymal-transition by activation of TGF-β/SMAD signaling

Daniel J. Devine, W. Grizzle, M. Mulekar, 2013, Oncogene.

Characteristics of PBMC obtained from leukapheresis products and tumor biopsies of patients with non-small cell lung cancer.

E. Hirschowitz, J. Yannelli, G. Hidalgo, 2009, Oncology reports.

Effect of talactoferrin alfa on the immune system in adults with non-small cell lung cancer.

G. Giaccone, J. Schlom, R. Madan, 2013, The oncologist.

Identification by digital immunohistochemistry of intratumoral changes of immune infiltrates after vaccine in the absence of modifications of PBMC immune cell subsets

M. Merino, P. Pinto, J. Schlom, 2014, International journal of cancer.

Loss of Merlin induces metabolomic adaptation that engages dependence on Hedgehog signaling

S. Barnes, S. Bae, R. Samant, 2017, Scientific Reports.

Inhibition of TGF-b1 Signaling Promotes Central Memory T Cell Differentiation

J. Schlom, J. Greiner, J. Tucker, 2013 .

Inhibition of TGF-β1 Signaling Promotes Central Memory T Cell Differentiation

J. Schlom, S. Takai, J. Greiner, 2013, The Journal of Immunology.

Immune Impact Induced by PROSTVAC (PSA-TRICOM), a Therapeutic Vaccine for Prostate Cancer

S. Steinberg, J. Schlom, R. Madan, 2013, Cancer Immunology Research.

Q 1 2 Immune Q 2 Impact Induced by PROSTVAC ( PSA-TRICOM ) , Q 3 3 a Therapeutic Vaccine for Prostate Cancer 4 5

S. Steinberg, J. Schlom, R. Madan, 2013 .

Loss of Tumor Suppressor Merlin in Advanced Breast Cancer Is due to Post-translational Regulation*

K. Ye, M. Mulekar, R. Samant, 2011, The Journal of Biological Chemistry.

Loss of heterozygosity on chromosome 17q11-21 in cancers of women who have both breast and ovarian cancer.

A. Berchuck, J. Boyd, J. Barrett, 1995, American journal of obstetrics and gynecology.

microRNA-29 negatively regulates EMT regulator N-myc interactor in breast cancer

Daniel J. Devine, S. Bae, Karan P. Singh, 2014, Molecular Cancer.

Immunotherapy: Shifting the Balance of Cell-Mediated Immunity and Suppression in Human Prostate Cancer

J. Schlom, J. Gulley, K. Tsang, 2012, Cancers.

Elevated levels of Ser/Thr protein phosphatase 5 (PP5) in human breast cancer.

R. Samant, L. Shevde, Guofei Zhou, 2008, Biochimica et biophysica acta.

A combination trial of vaccine plus ipilimumab in metastatic castration-resistant prostate cancer patients: immune correlates

S. Steinberg, J. Schlom, R. Madan, 2014, Cancer Immunology, Immunotherapy.

Brachyury, a Driver of the Epithelial–Mesenchymal Transition, Is Overexpressed in Human Lung Tumors: An Opportunity for Novel Interventions against Lung Cancer

F. Guadagni, J. Schlom, A. Spila, 2012, Clinical Cancer Research.

Identification and characterization of agonist epitopes of the MUC1-C oncoprotein

J. Schlom, J. Gulley, M. Vergati, 2014, Cancer Immunology, Immunotherapy.

Up‐regulation of proliferative and migratory genes in regulatory T cells from patients with metastatic castration‐resistant prostate cancer

J. Schlom, C. Intrivici, Tin-Lap Lee, 2013, International journal of cancer.

Phase I trial of a recombinant yeast-CEA vaccine (GI-6207) in adults with metastatic CEA-expressing carcinoma

J. Schlom, R. Madan, Marijo Bilusic, 2014, Cancer Immunology, Immunotherapy.

Identification and characterization of agonist epitopes of the MUC1-C oncoprotein

J. Schlom, J. Gulley, M. Vergati, 2013, Journal of Immunotherapy for Cancer.

Identification and characterization of a cytotoxic T-lymphocyte agonist epitope of brachyury, a transcription factor involved in epithelial to mesenchymal transition and metastasis

J. Schlom, J. Greiner, K. Tsang, 2014, Cancer Immunology, Immunotherapy.